首页> 外国专利> PEPTIDE, POLYNUCLEOTIDE, VECTOR, TRANSFORMANT, NFκB INHIBITOR, AND THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH ACCELERATED NFκB ACTIVITY

PEPTIDE, POLYNUCLEOTIDE, VECTOR, TRANSFORMANT, NFκB INHIBITOR, AND THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH ACCELERATED NFκB ACTIVITY

机译:促进NFκB活性相关的疾病的肽,多核苷酸,矢量,转化子,NFκB抑制剂和治疗剂

摘要

This peptide has an NFκB inhibitory effect and is any one of the following peptides: (a) a peptide comprising any amino acid sequence from SEQ ID NOs: 1-5; (b) a peptide having an NFκB inhibitory effect and comprising any amino acid sequence from SEQ ID NOs: 1-5, wherein one or a plurality of amino acid residues having been replaced, deleted and/or added; (c) a peptide having an NFκB inhibitory effect and comprising an amino acid sequence that is at least 80% homologous with any amino acid sequence from SEQ ID NOs: 1-5; (d) a peptide in which a cell-penetrating peptide is fused with any peptide selected from (a)-(c); and (e) a peptide in which a Met residue, a MetAla residue or an Ala residue is added to the N terminal of any peptide selected from (a)-(d).
机译:该肽具有NFκB抑制作用,并且是以下肽中的任何一种:(a)包含来自SEQ ID NO:1-5的任何氨基酸序列的肽; (b)具有NFκB抑制作用的肽,其包含SEQ ID NO:1-5的任何氨基酸序列,其中一个或多个氨基酸残基已被替换,缺失和/或添加; (c)具有NFκB抑制作用的肽,其包含与SEQ ID NO:1-5的任何氨基酸序列至少80%同源的氨基酸序列; (d)一种肽,其中将穿透细胞的肽与选自(a)-(c)的任何肽融合; (e)一种肽,其中Met残基,MetAla残基或Ala残基被添加至选自(a)-(d)的任何肽的N末端。

著录项

  • 公开/公告号WO2016098838A1

    专利类型

  • 公开/公告日2016-06-23

    原文格式PDF

  • 申请/专利权人 ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE;

    申请/专利号WO2015JP85286

  • 发明设计人 OKAMOTO KAZUKI;

    申请日2015-12-16

  • 分类号C12N15/09;A61K38;A61K48;A61P29;C07K14/47;C07K19;C12N1/15;C12N1/19;C12N1/21;C12N5/10;

  • 国家 WO

  • 入库时间 2022-08-21 14:17:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号